The landscape of treatment in multiple myeloma (MM) is rapidly changing. Based on an extensive review of the recent literature, we propose an update of our recommendations on myeloma care [1], to be used by Belgian hematologists as a reference for daily practice. Levels of evidence and grades of recommendations are based on previously published methods [2]. We recommend participation in clinical trials to gain knowledge in the fast-evolving field of MM treatment.
Vekemans, M.-C., Doyen, C., Caers, J., Wu, K., Kentos, A., Mineur, P., Michaux, L., Delforge, M., & Meuleman, N. (2022). Recommendations on the management of multiple myeloma in 2020. Acta Clinica Belgica, 77(2), 445-461. https://doi.org/10.1080/17843286.2020.1860411 (Original work published 2022)